TRI.TO -0.02C -1.89GFL.TO 2.01BRK.B -4.78PLUS -0.79TGTX 1.01LLY -33.23SU.TO 2.79
Pfizer Inc (PFE)

NYSE:PFE

Pfizer Inc (PFE)

30.03
-0.39 (1.28%)
as of Oct 23, 2026, 8:00:00 pm Market Closed.
585 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
DON'T BUY

Pfizer Inc(PFE)

Mar 24, 2003
More expensive in the drug sector. Merk is a better buy.
Photo of Peter Arender, CFAPeter Arender, CFAUnlock Rating
$30.99

Stock price when the opinion was issued

$30.03

As of Oct 23, 2026. Market Closed.

biotechnologypharmaceutical
Track your Stocks in your Watch List
BUY

Pfizer Inc(PFE)

Feb 06, 2003
Pretty good value. The merger will allow some cost cutting. A good price.
Photo of Ray SteeleRay SteeleUnlock Rating
$29.78

Stock price when the opinion was issued

$30.03

As of Oct 23, 2026. Market Closed.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Feb 04, 2003
Photo of Peter Arender, CFAPeter Arender, CFAUnlock Rating
$29.84

Stock price when the opinion was issued

$30.03

As of Oct 23, 2026. Market Closed.

biotechnologypharmaceutical
HOLD

Pfizer Inc(PFE)

Jan 13, 2003
Well run and strong management. Has grown so big that future growth is difficult.
Photo of Neil MurdockNeil MurdockUnlock Rating
$30.90

Stock price when the opinion was issued

$30.03

As of Oct 23, 2026. Market Closed.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Dec 27, 2002
Not doing much, but a good stock to own.
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$29.79

Stock price when the opinion was issued

$30.03

As of Oct 23, 2026. Market Closed.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Dec 16, 2002
Likes the pharmaceutical group. Acquisition of Pharmacia is positive.
Photo of David BurrowsDavid BurrowsUnlock Rating
$31.05

Stock price when the opinion was issued

$30.03

As of Oct 23, 2026. Market Closed.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Dec 12, 2002
Likes. Great value.
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$31.12

Stock price when the opinion was issued

$30.03

As of Oct 23, 2026. Market Closed.

biotechnologypharmaceutical
HOLD

Pfizer Inc(PFE)

Dec 06, 2002
Good merger made. Good company.
Photo of Paul O'NeilPaul O'NeilUnlock Rating
$31.00

Stock price when the opinion was issued

$30.03

As of Oct 23, 2026. Market Closed.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Dec 04, 2002
Positive on the drug industry.
Photo of Ray SteeleRay SteeleUnlock Rating
$30.94

Stock price when the opinion was issued

$30.03

As of Oct 23, 2026. Market Closed.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Nov 06, 2002
Strong pipeline. Republican win is good for pharmaceuticals.
Photo of Laura WallaceLaura WallaceUnlock Rating
$33.64

Stock price when the opinion was issued

$30.03

As of Oct 23, 2026. Market Closed.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Nov 04, 2002
Should start to see a rise.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$32.05

Stock price when the opinion was issued

$30.03

As of Oct 23, 2026. Market Closed.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Oct 07, 2002
Top quality company. Cheap. Good sector for the long term.
Photo of Brad WillockBrad WillockUnlock Rating
$28.30

Stock price when the opinion was issued

$30.03

As of Oct 23, 2026. Market Closed.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Oct 04, 2002
Sector has been hit hard. A very liquid stock.
Photo of Arthur HeinmaaArthur HeinmaaUnlock Rating
$28.55

Stock price when the opinion was issued

$30.03

As of Oct 23, 2026. Market Closed.

biotechnologypharmaceutical
DON'T BUY

Pfizer Inc(PFE)

Sep 24, 2002
Governments are trying to cut health care costs. Sector seems to be weak.
Photo of David BurrowsDavid BurrowsUnlock Rating
$28.00

Stock price when the opinion was issued

$30.03

As of Oct 23, 2026. Market Closed.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Sep 19, 2002
US pharmaceutical sector is very cheap now.
Photo of John ZechnerJohn ZechnerUnlock Rating
$29.05

Stock price when the opinion was issued

$30.03

As of Oct 23, 2026. Market Closed.

biotechnologypharmaceutical
Showing 796 to 810 of 894 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

AMZN -2.38$248
META -6.23$642.62
VRT -1.27$194.32
WFC -0.62$82.39
ZS 17.39$255.15

Today's Top Picks

TRI.TO -0.02$172.41
C -1.89$120.62
GFL.TO 2.01$63.75
BRK.B -4.78$542.19
PLUS -0.79$95.36

Popular Articles

Latest Sell Signals

DOV 0$
BA 0.8$188.35
AC.TO -1.03$21.11
BB.TO 0.44$12.46
TSM 6.16$418.51

Most Recent Experts

Stephanie Link, Chief investment strategist, Hightower

Stephanie Link, Chief investment strategist, Hightower

Hightower

Jason Snipe, CIO, Odyssey Capital Advisors

Jason Snipe, CIO, Odyssey Capital Advisors

Odyssey Capital Advisors

Rob Sechan, Managing Partner, New Edge Capital

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Jim Lebenthal

Jim Lebenthal

Cerity Partners

Tim Regan

Tim Regan

Kingwest & Company

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica

You may also like